Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Webmd Health Corp Issues Q2 2013 Revenue Guidance Above Analysts' Estimates; Comments On Q2 2013 Earnings Guidance; Raises FY 2013 Guidance


Tuesday, 7 May 2013 04:00pm EDT 

Webmd Health Corp announced that for fiscal 2013, it expects revenue to be approximately $450 million to $470 million, adjusted EBITDA to be approximately $75 million to $88 million and net loss from continuing operations to be approximately $(13.0) million to $(1.5) million, or $(0.26) to $(0.03) per diluted share. For second quarter of 2013, it expects revenue to be in excess of $115 million, adjusted EBITDA to be in excess of 18% of revenue, net loss from continuing operations to be approximately 1% of revenue. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $445 million, EBITDA of $78 million and EPS of $(0.30) for fiscal 2013; revenue of $108 million, EBITDA of $17 million and EPS of $(0.08) for second quarter of 2013. 

Company Quote

39.49
1.42 +3.73%
3:51pm EST